These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7656199)

  • 1. Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma.
    Meeus P; Stul MS; Mecucci C; Cassiman JJ; Van den Berghe H
    Cancer Genet Cytogenet; 1995 Aug; 83(1):25-7. PubMed ID: 7656199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
    Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
    Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC.
    Galiègue-Zouitina S; Collyn-d'Hooghe M; Denis C; Mainardi A; Hildebrand MP; Tilly H; Bastard C; Kerckaert JP
    Genes Chromosomes Cancer; 1994 Dec; 11(4):246-55. PubMed ID: 7533528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant.
    Laï JL; Michaux L; Dastugue N; Vasseur F; Daudignon A; Facon T; Bauters F; Zandecki M
    Cancer Genet Cytogenet; 1998 Jul; 104(2):133-8. PubMed ID: 9666807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
    Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
    Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
    Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
    Leukemia; 1993 Feb; 7(2):241-5. PubMed ID: 8426477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of PRAD1 gene in B-cell malignancy with t(11;14)(q13;q32) translocation].
    Iida S; Seto M; Yamamoto K; Ueda R
    Nihon Rinsho; 1992 Jun; 50(6):1374-9. PubMed ID: 1518159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines.
    Meeker TC; Sellers W; Harvey R; Withers D; Carey K; Xiao H; Block AM; Dadey B; Han T
    Leukemia; 1991 Sep; 5(9):733-7. PubMed ID: 1943225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
    Fonseca R; Witzig TE; Gertz MA; Kyle RA; Hoyer JD; Jalal SM; Greipp PR
    Br J Haematol; 1998 May; 101(2):296-301. PubMed ID: 9609525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of B-cell malignancy involving the BCL1/PRAD1 locus.
    Hayashi T; Ohno H; Yamabe H; Nasu K; Miyaoka K; Fujii H; Akaogi T; Konishi H; Maseki N; Akasaka T
    Int J Hematol; 1994 Jun; 59(4):281-96. PubMed ID: 8086622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation (11;14)(q13;q32) and partial trisomy 1q in a case of multiple myeloma.
    Kwong YL; Lie AK; Chan LC
    Am J Hematol; 1993 Nov; 44(3):212-3. PubMed ID: 8213777
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
    Rao PH; Cigudosa JC; Ning Y; Calasanz MJ; Iida S; Tagawa S; Michaeli J; Klein B; Dalla-Favera R; Jhanwar SC; Ried T; Chaganti RS
    Blood; 1998 Sep; 92(5):1743-8. PubMed ID: 9716604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.
    Sasaki K; Lu G; Saliba RM; Bashir Q; Hosing C; Popat U; Shah N; Parmar S; Dinh Y; Ahmed S; Shpall EJ; Kebriaei P; Shah JJ; Orlowski RZ; Champlin R; Qazilbash MH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1227-32. PubMed ID: 23733001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
    De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
    Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies.
    Raynaud SD; Bekri S; Leroux D; Grosgeorge J; Klein B; Bastard C; Gaudray P; Simon MP
    Genes Chromosomes Cancer; 1993 Oct; 8(2):80-7. PubMed ID: 7504521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoplastic plasma cells mimic mature neutrophils in plasma cell myeloma with t(11;14)(q13;q32).
    Wang W; Hu S
    Blood; 2015 Apr; 125(18):2875. PubMed ID: 26120642
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
    Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
    Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.
    Fonseca R; Blood EA; Oken MM; Kyle RA; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Hoyer JD; Harrington D; Kay NE; Van Ness B; Greipp PR
    Blood; 2002 May; 99(10):3735-41. PubMed ID: 11986230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.